| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Chemistry and Biochemistry (K.E.B., R.M.C.), Mass Spectrometry Research Center, Vanderbilt University, Nashville, Tennessee 37221; and Departments of Pediatrics (T.D., S.K.D.), Cell and Developmental Biology (S.T., S.K.D.), and Pharmacology (S.K.D.), Division of Reproductive and Developmental Biology, and Department of Biostatistics (D.M.), Vanderbilt University Medical Center, Nashville, Tennessee 37222
Address all correspondence and requests for reprints to: S. K. Dey, Vanderbilt University Medical Center, MCN D4100, 1161 21st Avenue South, Nashville, Tennessee 37232. E-mail: sk.dey{at}vanderbilt.edu; or Richard M. Caprioli, Mass Spectrometry Research Center, Vanderbilt University, 465 21st Avenue South, Suite 9160 MRB III, Nashville, Tennessee 37221. E-mail: r.caprioli{at}vanderbilt.edu.
A reciprocal interaction between the implantation-competent blastocyst and receptive uterus is an absolute requirement for implantation, a process crucial for pregnancy success. A comprehensive understanding of this interaction has yet to be realized. One major difficulty in clearly defining this discourse is the complexity of the implantation process involving heterogeneous cell types of both the uterus and blastocyst, each endowed with unique molecular signatures that show dynamic changes during the course of pregnancy. Whereas gene expression studies by in situ hybridization or immunohistochemistry have shown differential expression patterns of specific genes during implantation, there is no report how numerous signaling proteins are spatially displayed at specific times and stages of implantation in the context of blastocyst-uterine juxtaposition. Using in situ imaging (matrix assisted laser desorption/ionization) mass spectrometry directly on uterine sections, here we provide molecular composition, relative abundance, and spatial distribution of a large number of proteins during the periimplantation period. This approach has allowed us for the first time to generate in situ proteome profiles of implantation and interimplantation sites in mice in a region- and stage-specific manner with the progression of implantation. This application is reliable because patterns of expression of several proteins displayed by in situ imaging mass spectrometry correlate well with in situ hybridization results. More interestingly, the use of this approach has provided new insights regarding uterine biology of cytosolic phospholipase A2
null females that show implantation defects.
This article has been cited by other articles:
![]() |
N. Brown, J. D. Morrow, J. C. Slaughter, B. C. Paria, and J. Reese Restoration of On-Time Embryo Implantation Corrects the Timing of Parturition in Cytosolic Phospholipase A2 Group IVA Deficient Mice Biol Reprod, December 1, 2009; 81(6): 1131 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Burnum, D. S. Cornett, S. M. Puolitaival, S. B. Milne, D. S. Myers, S. Tranguch, H. A. Brown, S. K. Dey, and R. M. Caprioli Spatial and temporal alterations of phospholipids determined by mass spectrometry during mouse embryo implantation J. Lipid Res., November 1, 2009; 50(11): 2290 - 2298. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Seeley and R. M. Caprioli Mass Spectrometry Special Feature: Molecular imaging of proteins in tissues by mass spectrometry PNAS, November 25, 2008; 105(47): 18126 - 18131. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |